Searchable abstracts of presentations at key conferences in endocrinology

ea0071002 | Novel model of sex steroid deficiency in mice to study the physiological effects of delayed and suppressed puberty | BES2020

Novel model of sex steroid deficiency in mice to study the physiological effects of delayed and suppressed puberty

Kim Na Ri , Rougin Khalil , Karel David , Leen Antonio , Dieter Schollaert , Ludo Deboel , HerckErik Van , Nele Wardenier , Martine Cools , Brigitte Decallonne , Frank Claessens , Vanessa Dubois , Dirk Vanderschueren

Background: Sex steroids are critical for skeletal development and maturation during puberty as well as skeletal maintenance during adult life. However, the exact time during puberty when sex steroids have the highest impact as well as the ability of bone to recover from transient sex steroid deficiency is unclear. The latter is highly relevant in the clinical context of delayed puberty, since the impact of a delayed pubertal onset on adult bone health remains elusive. Surgica...

ea0029p433 | Clinical case reports - Thyroid/Others | ICEECE2012

Van Wyk e Grumbach syndrome: case report

Francisco B. , Haber J. , Santos R.

Introduction: In 1960, Van Wyk and Grumbach described the association of hypothyroidism and precocious puberty. Hypothyroidism leads to delayed bone age and a reduction in growth rate by reducing the amplitude of GH pulses. When precocious puberty is associated with thyroid hypofunction, estrogen action on the epiphyseal plates reduce this delay. We report the case of a child who developed incomplete puberty and reduced growth rate, caused by primary hypothyroidism.<p clas...

ea0039oc3.1 | Oral Communications 3 | BSPED2015

Long standing autoimmune hypothyroidism with macro-orchidism and pituitary mass: Van Wyk-Grumbach syndrome

Alsaffar Hussain , Phanse Supriya , Frerichs Carley , Didi Mohammed , Senniappan Senthil

Introduction: Van Wyk-Grumbach syndrome was first described in 1960 in patients presenting with long standing juvenile hypothyroidism, delayed bone age and precocious puberty. Literature review indicates only few cases reported in males compared to females. We are reporting this case in a male patient who presented with short stature.Case: A 7.25-year-old boy was referred for endocrine opinion due to short stature. He had not grown over the last 18 month...

ea0084ps3-11-97 | Case Reports | ETA2022

Van wyk-grumbach syndrome: an unusual presentation of long-standing primary hypothyroidism mimicking ovarian tumor

Wejaphikul Karn , Dejkhamron Prapai , Unachak Kevalee

Introduction: Children with long-standing primary hypothyroidism usually have growth retardation, neurodevelopmental impairment, and delayed puberty. However, paradoxical precocious puberty, namely Van Wyk-Grumbach syndrome (VWGS), has been described. The postulated mechanism is high levels of TSH stimulate gonadal FSH receptors, resulting in ovarian over-stimulation and precocious puberty. Since the enlarged ovarian cyst is commonly found in VWGS, malignancy is often suspecte...

ea0066p80 | Thyroid | BSPED2019

Incomplete isosexual precocious puberty with macroadenoma: a rare presentation of primary hypothyroidism (Van Wyk-Grumbach Syndrome)

Mehta Sonalika , Rajvanshi Nikhil , Verma Prashant Kumar

Introduction: Precocious puberty occurs is associated with initial increase in linear growth and acceleration of bone maturity presenting as advanced bone age with early epiphyseal fusion which ultimately results in short stature. ‘Van Wyk Grumbach Syndrome’ (VWGS) is a rare syndrome associated with incomplete isosexual precocious puberty and macroadenoma seen in cases of longstanding, untreated hypothyroidism is associated with a delayed bone age. Complete resolutio...

ea0057037 | Euglycemic ketoacidosis in diabetes type 1 | BES2018

Euglycemic ketoacidosis in diabetes type 1

Van den Mooter L , Mathieu C

Background: SGLT2i have shown promising results as an adjunct therapy in T1DM, resulting in better glucose control, weight loss and lower blood pressure. No increase in hypoglycemia risk, in particular severe hypoglycemia, was observed, but, an mild increased risk of (euglycemic) diabetic DKA was reported (Van den Mooter L. et al. Exp Opinion Pharm 2018).Case report: A 49-year-old Caucasian female nurse with underlying type 1 diabetes was admitt...

ea0099p176 | Late-Breaking | ECE2024

[18F]FET PET-MRI; A diagnostic tool to improve medical decision-making for small functioning pituitary adenomas in acromegaly patients

van der Groef Romy , Pruis Ilanah , Balvers Rutger , Celine Refardt Julie , Veldhuijzen van Zanten Sophie , Neggers Sebastian

Background: Patients with acromegaly without detectable pituitary adenoma on conventional MRI are often excluded from adenomectomy due to inherent challenges of precise surgical planning, significantly limiting both their therapeutic options and chances of curation. Previous research showed that O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) PET-MRI is an accurate diagnostic tool to detect small functional pituitary adenomas (1). The present study aims to investigate the diagnos...

ea0064040 | Prepubertal gynecomastia: what to suspect first? | BES2019

Prepubertal gynecomastia: what to suspect first?

Karolien Van de Maele , Daniel Klink , Jean De Schepper

Introduction: Most cases of prepubertal gynecomastia are classified as idiopathic. However, an exogenous or endogenous hyperestrogenism (from estrogen producing testis or adrenal tumors) has always to be excluded. Other rare underlying endocrine causes are congenital adrenal hyperplasia, aromatase excess, hyperthyroidism and hyperprolactinemia1,2.We report a transient hyperprolactinemia, beside other ignored clinical and hormonal signs of estr...

ea0037ep734 | Pituitary: clinical | ECE2015

Association of serum IGF1 concentration with efficacy and safety measures in adults with GH deficiency with different GH treatment regimes: a randomised clinical trial

van Bunderen Christa C. , Lips Paul , Kramer Mark H. , Drent Madeleine L.

Introduction: The current guidelines state that the goals of growth hormone (GH) therapy should be an appropriate clinical response and avoidance of side effects. The target level for IGF1 is commonly the upper half of the reference range, although no published studies offer specific guidance in this regard. Therefore, the aim of the present study is to investigate associations between IGF1 levels within the reference range and several efficacy and safety measures of GH treatm...

ea0021cm3.2 | Management of congenital adrenal hyperplasia across the lifespan | SFEBES2009

Testicular adrenal rest tissue and male fertility in CAH

Claahsen-van der Grinten Hedi , Otten Barto , Sweep Fred , Hermus Ad

Infertility is a serious problem in female as well in male CAH patients. The most important cause of male infertility in CAH patients is the presence of testicular adrenal rest tumors (TART). The reported prevalence in adult CAH patients is up to 96%. TART have no malignant features but because of their typical localization near the mediastinum testis, longstanding compression of the seminiferous tubules may lead to obstructive azoospermia and irreversible damage of testicular...